Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04032262 · ClinicalTrials.gov registry record · NA
Parkinson's Disease and Digestive Health
A NA study, sponsored by Augusta University.
- Completed
- Registry status
- NA
- Development phase
- 25
- Enrollment target
NCT04032262 is a NA study that has completed, run by Augusta University. The registered enrollment target is 25 participants.
The verdict
NCT04032262, a NA study, has completed, sponsored by Augusta University.
- COMPLETED
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
Study Summary
This study focuses on the relationship between the brain and the gut, and additionally will foster collaboration between Movement Disorder experts and Neurogastroenterologists to provide critical information and lead to innovative therapies in the future to treat GI dysfunction of Parkinson's Disease.
Interventions
- DIAGNOSTIC_TEST Gastrointestinal and Parkinson's Disease
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2017-10-04 |
| Est. Completion | 2021-12-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04032262
The ClinicalTrials.gov registry entry for NCT04032262 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Augusta University, which has 106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Gastrointestinal and Parkinson's Disease is the first listed.
NCT04032262 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04032262 about?
NCT04032262 is a clinical study titled "Parkinson's Disease and Digestive Health". This study focuses on the relationship between the brain and the gut, and additionally will foster collaboration between Movement Disorder experts and Neurogastroenterologists to provide critical information and lead to innovative therapies in the future to treat GI dysfunction of Parkinson's Diseas...
What is the current status of trial NCT04032262?
This trial is currently completed. It is a NA study. The enrollment target is 25 participants. The study started on 2017-10-04. Estimated completion is 2021-12-30.
What interventions are being tested in trial NCT04032262?
The interventions under investigation include: Gastrointestinal and Parkinson's Disease (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04032262?
This trial is sponsored by Augusta University, which has 106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.